NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment

por Haviland, J. A., Reiland, H., Butz, D. E., Tonelli, M., Porter, W. P., Zucchi, R., Scanlan, T. S., Chiellini, G., Assadi-Porter, F. M.
Publicado 2013